Contract Notice Detail

Summary Information

Summary Information
35,747.68 Euro
 
ULS São Jose 51032024 
Ifosfamida 1000 mg pó sol inj fr IV e Ifosfamida 2000 mg pó sol inj fr IV  
Tendering Phase
Awarded
Ifosfamida 1000 mg pó sol inj fr IV e Ifosfamida 2000 mg pó sol inj fr IV  
VortalGOV - Acquisition under a Framework Agreement (via Direct Award) 
Lot NameLot Base PriceExpected Duration
I17 - IFOSFAMIDA [1G; PÓ P/A SOL. INJ.; FRS]-6 (Months)
I18 - IFOSFAMIDA [2G; PÓ P/A SOL. INJ.; FRS]-6 (Months)

Object of the Contract

Object of the Contract
Supplies Acquisition 
Rua José António Serrano 1150-199 Arroios Lisboa PORTUGAL  
33600000-6 - Pharmaceutical products
 
 
 

Scheduling

Scheduling
6/24/2024 8:41 AM (UTC +1 hour)
 
9/4/2023 8:19 AM (UTC +1 hour)
 
6/26/2024 4:00 PM (UTC +1 hour)
 

Financial Settings

Financial Settings
No 

Contract Documents

Contract Documents
Document NameDescriptionDoc Classification
convite 51032024.pdfconvite 51032024.pdfDownload

Object of contract

No 
No 

Legal, economic, financial and technical information

No 

Questionnaire

Questionnaire
1
Lot Title
I17 - IFOSFAMIDA [1G; PÓ P/A SOL. INJ.; FRS]
Base Price
1 124,48

1.1   Bill of Quantities  *  
This price list has extra requirements. Make sure everything is completed, under each article line.

Item Code Description Quantity Unit
I17 IFOSFAMIDA [1G; PÓ P/A SOL. INJ.; FRS] 25,000000 NXTWY.UMT.17649
Buyer Comment: 503347345 | Baxter - Médico Farmacêutica, Lda. | CPA:2023491/110/0153 | NºAIM:4408688;
TOTAL (The amounts shown do not include VAT)
2
Lot Title
I18 - IFOSFAMIDA [2G; PÓ P/A SOL. INJ.; FRS]
Base Price
34 623,20

2.1   Bill of Quantities  *  
This price list has extra requirements. Make sure everything is completed, under each article line.

Item Code Description Quantity Unit
I18 IFOSFAMIDA [2G; PÓ P/A SOL. INJ.; FRS] 400,000000 NXTWY.UMT.17649
Buyer Comment: 503347345 | Baxter - Médico Farmacêutica, Lda. | CPA:2023491/110/0154 | NºAIM:4408787;
TOTAL (The amounts shown do not include VAT)

Evaluation

Evaluation
Vision

Avaliação

Definir modelo de avaliação
Modalidade de avaliação
Método de Avaliação
Divulgar critérios de avaliação

Critérios da Avaliação

1 - I17 - IFOSFAMIDA [1G; PÓ P/A SOL. INJ.; FRS]

Critérios da Avaliação

Descrição
Tipo de Fator
Peso (%)
1.PreçoPreço100%

Normas de desempate

2 - I18 - IFOSFAMIDA [2G; PÓ P/A SOL. INJ.; FRS]

Critérios da Avaliação

Descrição
Tipo de Fator
Peso (%)
1.Preço-100%

Normas de desempate

Public Messages

Public Messages
TypeReferenceSubjectDate
No items found...